
Myomo MYO
€ 0.60
0.0%
Geschäftsbericht 2025
hinzugefügt 09.03.2026
Myomo EV/EBITDA 2011-2026 | MYO
EV/EBITDA Jährlich Myomo
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.96 | -3.03 | -0.281 | -1.37 | -0.937 | - | -0.273 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.273 | -3.03 | -1.48 |
EV/EBITDA anderer Aktien in der Medizinische Geräte
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
-8.6 | $ 11.75 | - | $ 1.76 B | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
-1.69 | $ 8.98 | - | $ 322 M | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.41 | - | $ 121 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.01 | - | $ 1.22 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.35 | - | $ 21.8 M | ||
|
Inogen
INGN
|
17.4 | $ 6.32 | - | $ 168 M | ||
|
IRadimed Corporation
IRMD
|
46 | $ 100.97 | - | $ 1.28 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
LivaNova PLC
LIVN
|
215 | $ 62.4 | - | $ 3.4 B | ||
|
LENSAR
LNSR
|
-1.48 | $ 5.56 | - | $ 64 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 32.61 | - | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 36.56 | - | $ 1.13 B | ||
|
Medtronic PLC
MDT
|
24.4 | $ 86.58 | - | $ 111 B | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
26.4 | $ 24.7 | - | $ 209 M | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.7 | - | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
-0.459 | $ 2.16 | - | $ 3.37 M | ||
|
InspireMD
NSPR
|
-1.11 | $ 1.79 | 3.47 % | $ 115 M | ||
|
Profound Medical Corp.
PROF
|
-7.43 | $ 5.15 | - | $ 180 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Orthofix Medical
OFIX
|
31.1 | $ 11.72 | - | $ 464 M | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 11.48 | - | $ 1.55 B | ||
|
Penumbra
PEN
|
938 | $ 334.17 | - | $ 13 B | ||
|
Nano-X Imaging Ltd.
NNOX
|
-0.00869 | $ 2.4 | - | $ 141 M | ||
|
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.91 | - | $ 146 M | ||
|
Insulet Corporation
PODD
|
95.3 | $ 225.5 | - | $ 15.9 B | ||
|
Quanterix Corporation
QTRX
|
-14.7 | $ 3.82 | - | $ 163 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 15.91 | - | $ 373 M |